Regulatory Developments April 2020

03a_RegNews_Alternate_770x2953.jpg

Learn about recent draft guidances, including for labeling biologics, developing drugs for Sanfilippo syndrome, interchangeable biosimilars, and immunotoxic potential of drugs

Table of Contents
Regulatory Developments
April 2020

Related Stories